Introduction
The presence and persistence of pharmaceuticals in the environment and their fate are increasingly pertinent issues ( Alvarez-Ruiz et al., 2015; Ngumba et al., 2016) . Parallel to this, there are concerns regarding the preservation of aquatic ecosystems and the potential contamination risk of public water supplies. This has encouraged studies aimed at identifying and quantifying pharmaceutical waste in the environment so that the risk posed can be evaluated, and subsequently, the disposal thereof can be minimized and efficient processes to remove these drugs can be developed (Maranho et al., 2014; Mwanamoki et al., 2014; Alvarez-Ruiz et al., 2015) .
Considering the significant threat to humans, animals, and agriculture, antibiotics are one of the most relevant emerging pollutants in the environment. Their continuous interactions with and inhibitory effects on microorganisms may cause damage, including antibiotic resistance induction (Adachi et al., 2013) . Fluoroquinolones, such as enrofloxacin, are broadspectrum synthetic antibiotics commonly used in human and veterinary medicine (Trouchon and Lefebvre, 2016) as well as in agriculture and aquaculture (Migliore et al., 1996) . Fluoroquinolone antibiotics typically have a fluoro group attached to the central ring structure at position 6. Enrofloxacin is distinguished by three ionisable functional groups, namely a piperazine substituent at N-4, a dihydroquinoline ring at N-1, and the 3-carbonyl group (Figure 1 ). These antibiotics show strong antibacterial activity and are somewhat resistant to abiotic and biotic degradation (Migliore et al., 1996) . Orally administered as medicines, only a small percentage of fluoroquinolones are adsorbed and metabolized, the rest is excreted. For most fluoroquinolones, the elimination half-life has been reported to be 16 h and it is therefore likely that they will be excreted largely unchanged with less than 25% metabolization. Within this context, fluoroquinolones are acknowledged pollutants that have already been detected in different environmental compartments, such as up to 248 ng l ¡1 in surface waters (Wagil et al., 2014) , up to 49 ng l ¡1 in groundwater (Ma et al., 2015) , and up to 7.7 mg kg ¡1 in sediment (Hu et al., 2012) have been reported. Another important factor to consider regarding pharmaceutical pollution is that during wastewater treatment or even in the environment, the pollutants may be only partially degraded and thus numerous transformation products (TPs) are generated which may be more toxic than the precursor molecules (Escher and Fenner, 2011) . Generally, drugs and their TPs are found in sub-mg l ¡1 concentrations in unknown complex matrices making it necessary to use analytical methods of high sensitivity and selectivity to detect and identify them. Moreover, the lack of analytical standards for TPs complicates the analysis thereof. Identifying unknown compounds where standards are not available is challenging. The first step is assessing whether prediction of TPs using computational (in silico) prediction tools is possible. Furthermore, a proper prediction of their formation may be done considering the organism or the system where the TPs are formed (Bletsou et al., 2015) . In a second step, Figure 1 . Chemical structure of enrofloxacin; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid.
when it is possible to draw up a list of potential TPs assembled from the literature or from prediction models, a suspect screening can be done in samples for those candidates. However, whenever predictions are unavailable, non-target screening analyses are performed to identify novel TPs with sophisticated post-acquisition data tools, like MZmine (http:// mzmine.sourceforge.net/), and supplementary analytical techniques (Bletsou et al., 2015) .
The abiotic and biotic degradation of several pharmaceuticals in sediments and the water column are well understood (L€ offler et al., 2005; Jiang et al., 2010) , however, little data on the fate of enrofloxacin are available and if its TPs are equally, or potentially even more harmful than the parent compound. Due to the inability of wastewater treatment processes to fully eliminate pharmaceuticals, together with various contamination input sources, antibiotics such as fluoroquinolones, especially enrofloxacin, are bound to end up in the environment as already evident from monitoring studies (reviewed by Homem and Santos, 2011) . It is therefore important to understand the environmental fate of these compounds and the ecological threat their natural breakdown products may pose to the environmental compartments they accumulate in.
The aims of this study were, therefore, to identify the TPs of enrofloxacin in lake sediments and to test the formed TPs for antimicrobial properties and their ecotoxicological effects using a modified antimicrobial susceptibility test and a green algae growth test, respectively, to understand the fate and effects of enrofloxacin pollution on the environment, specifically freshwater lakes.
Materials and methods

Biodegradation with lake sediments
Sediment samples were collected from M€ uggelsee, a lake in the eastern suburbs of Berlin, the capital city of Germany, approximately 200 m from the shoreline by removing the first 15 cm of sediment using a bottom sampler. After drying the sediment at 30 C, a dry weight of 1 g per sediment sample was used per replicate for both the treatment and the controls. Three controls were prepared, i.e., (1) 10 mg l ¡1 enrofloxacin in 10 ml water to test its natural degradation, (2) 10 ml water lacking enrofloxacin in the natural sediment from M€ uggelsee to investigate if the sediment was previously contaminated with enrofloxacin, and (3) 10 mg l ¡1 enrofloxacin (10 ml) in sterilized sediment to eliminate the influence of the native microflora. The sediment samples were sterilized by autoclaving at 121 C for 35 min (16 psi). For the treatment samples, 10 ml of 10 mg enrofloxacin l ¡1 was added to the natural sediments samples from M€ uggelsee. The samples were incubated at 20 C, shaking at 145 rpm, in the absence of light. Thereafter, batch experiments were performed in duplicate for different periods of time exposures (5, 24, 48, and 72 h). After centrifugal separating at 1700 £ g, 1 ml of supernatant was collected for direct analysis, after filtration. To concentrate the remaining supernatant volume, the samples were lyophilized and reconstituted with 1 ml of a 5% acetonitrile solution in ultrapure water. The sediments from the treatment samples were extracted with sequential acetonitrile and methanol solvents steps. The extracts were lyophilized and reconstituted in 1 ml of a 5% acetonitrile solution in ultrapure water and analysed. The recovery of enrofloxacin after concentration was test in methanol, acetonitrile, and water (n D 3) by spiking with 1 mg l ¡1 enrofloxacin before freeze drying at ¡50.3 C and a pressure of 6.1 mbar in a Lio 5P lyophilisator (Kambi c Laboratorijska oprema). The method recovery percentage ranged from 76% to 103% for the three solvents. The exposure concentration of 10 mg l ¡1 enrofloxacin (soluble up to 146 mg l ¡1 in water) was selected in order for all breakdown products produced to be identified, i.e. that the concentration of a specific TP did not fall below the limit of detection (10 pg on column) and quantification (50 pg on column). Also, the concentration selected also serves as a worst case scenario to assess the effect of breakdown products of enrofloxacin in the environment.
Product identification using qualitative analysis
The prepared samples were analysed using Liquid Chromatography Electrospray Ionization Quadrupole Ion-Mobility Time-of-Flight Mass Spectrometry (LC-ESI-IMS-TOF) (Waters Co.), subjected to high-resolution mass spectrometry. Chromatographic separation was achieved on a Kinetex C18 column (100 mm £ 2.1 mm; 2.6 mm; Phenomenex) eluted with mixtures of 0.1% formic acid in ultrapure water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) starting with 5% B for 3 min. Over the next 9 min, mobile phase B was increased from 5% to 60% and further to 95% over the next 2 min. From the 14th to the 20th min mobile phase B was kept constant at 95% B. Over the next 2 min phase B was reduced to 5% and the column was allowed to re-equilibrate for 4 min before the next injection. The oven temperature was set at 40 C, the flow rate was 0.25 ml min ¡1 and the injection volume was 5 ml. The mass spectrometric analyses were performed in the positive ionization mode (electrospray), and the operating conditions were as follows: drying gas flow: 8 l min ¡1 ; desolvation temperature: 200 C; capillary voltage: 4.5 kV; nebulizer pressure: 4 bar; spectra acquisition rate: 2 Hz at full MS mode, operating with a scan range from m/z 50 to m/z 1000. Using the described analytical settings, enrofloxacin had a retention time of 6.51 min and m/z of 360.1. MZmine 2 (Version 2.21) which is a modular framework for processing, visualizing, and analysing mass spectrometry-based molecular profile data, was used for data extraction, deconvolution, and alignment (Bletsou et al., 2015) .
Ecotoxicological tests
The freshwater algae growth rate inhibition test with the single-celled green algae Desmodesmus subspicatus was performed according to the DIN EN ISO 8692:2012-06.
For the antibiotic susceptibility assay, three controls at the inception of the experiment were prepared, i.e., Provisoli medium (Pflugmacher et al., 2006) as negative control for media samples, enrofloxacin at a concentration of 10 mg l ¡1 in media as a positive control, and unexposed sediment as a negative sediment control. The effect of the sediment microbe population on the antibiotic nature of enrofloxacin was evaluated by preparing a negative control of media and sediment, 10 mg l ¡1 enrofloxacin in media together with the sediment, and 10 mg l ¡1 enrofloxacin in media with autoclaved sediment. All exposure sets were conducted in quadruplicate.
A modified version of the Kirby Bauer disk diffusion assay (Bauer et al., 1996) , was used to evaluate the bactericidal effect of enrofloxacin after treatment with the sediments microbes. In short, single colonies of Escherichia coli Top 10 (ThermoFisher Scientific) were aseptically transferred to nutrient broth and cultivated overnight at 37 C. Thereafter, spread plates of the culture were prepared on nutrient agar (prepared according to supplier specifications) and allowed to dry for 5 min. Sterile diffusion disks were dipped in each of the samples and placed on the prepared plates (one disk per replicate per plate). The plates were incubated overnight at 37 C. The inhibition zone radius per replicate was determined in millimetre.
Statistical analysis
Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) software (version 21, SPSS, Inc., Chicago, IL, USA; a D 0.05, 95% CI). Data were tested for normality and homogeneity of variance using Shapiro-Wilk test and Levene's test, respectively. A one-way analysis of variance test was performed followed by a Turkeys post hoc test to identify significant differences between the treatments and controls (a D 0.05).
Results and discussion
Degradation products identification
For the first three sampling points, i.e., 5, 24, and 48 h, the concentration of enrofloxacin remained statistically constant in the controls and treatments (p > 0.05) and no TP products could be identified, probably as the concentration of the TPs were below the limit of detection. The results obtained in the control experiments are presented in Figure 2 . Comparing Figure 2A versus 2B it is evident that during the three days of exposure, the enrofloxacin concentration of 10 mg l ¡1 in media remained unchanged (p > 0.05), demonstrating its stability under the experimental conditions. Figure 2C showed that no free enrofloxacin could be detected in the untreated sediment.
In the control experiment, which consisted of enrofloxacin in the sterile sediment, neither enrofloxacin nor TPs could, however, not be detected after 72 h of incubation ( Figure 2D ) suggesting that it could have adsorbed to the sediment. Fluoroquinolones have previously been reported to form strong bonds with ions such Ca 2C , Mg 2C , Fe 3C , or Al 3C causing them to adsorb onto sewage, sludge, soil, and sediment, which is said to cause their environmental resilience and resistance to microbial degradation (Al-Ahmad et al., 1999; Ingerslev and Halling-Sørensen, 2000; K€ ummerer et al., 2000) . Enrofloxacin is said to have a very high affinity for sludge, soils, and sediments (Van Doorslaer et al., 2014) . Compared to other antibiotics, fluoroquinolones have a very high sorbent coefficient of 260 to 5610 l kg ¡1 (Nowara et al., 1997) . It was previously shown that the adsorption of fluoroquinolones onto clay surfaces is attributed to the carboxylic acid moiety binding the positively charged clay surface (Stern layer), which coincidentally is also the functional moiety responsible for gyrase binding together with the ketone of C4 (Nowara et al., 1997; Marengo et al., 1997) .
After 72 h, no enrofloxacin could be detected in the treated samples. Using the software MZmine, after peak deconvolution and alignment of the chromatograms obtained from the treatment and control samples, three compounds were identified in the enrofloxacin treated natural sediment samples, i.e., two degradation products were found in the concentrated media samples (m/z 308 and m/z 332) and another in the sediment extracts (m/z 318). Figure 3 (A to C) presents the high-resolution MS/MS spectrums obtained to confirm the proposed structures. All degradation products identified were formed through modifications occurring in the essential structure of the quinolones. For all three TPs, the piperazine ring remained unchanged (Figure 4) . The two TPs in the concentrated media samples were identified as 2-Cyclopropylamino-4-(4-ethyl-1-piperazinyl)-5-fluorobenzoic acid (m/z 308) and 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-3-hydroxy-4-1H-quinolinone (m/z 332), and the TP in the sediment extract was identified as 1-Cyclopropyl-6-(4-ethyl-1-piperazinyl)-5-fluoro-1H-indole-2,3-dione (m/z 318). The degradation of enrofloxacin by the brown rot fungus Gloeophyllum striatum and the metabolites formed were previously investigated (Wetzstein et al., 1997) . All three the degradation products identified in this study were also described by Wetzstein et al. (1997) , suggesting that the degradation could be attributed to microbial degradation. As no degradation products were detected in the control, where enrofloxacin was incubated with sterile sediment, this hypothesis is further supported, however, this should be further investigated in future to investigate if microbes were involved and if so, which microbes were responsible for the TPs identified.
Decarboxylation occurred in the essential structure of the enrofloxacin (Figure 4) , which irreversibly inactivates the drug because the carboxyl group is essential for the antibacterial activity of fluoroquinolones (Domagala, 1994) . The cleavage of the heterocyclic core of enrofloxacin was observed in the intermediate A and B (Figure 4 ).
Ecotoxicological tests
The algae growth rate inhibition test ( Figure 5 ) showed that the TPs formed had no significant effect on the specific growth rate of D. subspicatus compared to when cultivated in growth media only (negative control) (p D 0.087). Interestingly, enrofloxacin was previously reported to be toxic to green algae with an EC 50 of 5,568 mg l ¡1 (Ebert et al., 2011) . Yet, in this study, a concentration of 10 mg l ¡1 enrofloxacin had no statistical effect on the specific growth rate compared to that of the control (p D 0.426). The microalgae displayed the best specific growth rate in the samples from which enrofloxacin was incubated in sterile sediment for 3 days. It is plausible that the enrofloxacin was bound to the sediment, therefore unable to adversely affect the algae. The algae also could have benefitted from the addition of minerals and micronutrients supplied form samples in contact with the sediment.
The antibiotic susceptibility assay ( Figure 6 ) showed that after the 72 h biodegradation period of enrofloxacin (Treatment (sediment) and (liquid)), the products formed in the solution as well as those bound to the sediment, lost their antibiotic effects compared to the 10 mg l ¡1 enrofloxacin solution (Enro initial) (p < 0.05). This was expected as it was shown for the TP identification that enrofloxacin was decarboxylated. Interestingly, incubation of enrofloxacin with the sterilized sediment reduced the antibacterial properties of the enrofloxacin by 1.8-fold in the sediment (Positive control (sediment)) and 3.2-fold in the media (Positive control (media)) (p < 0.05). As sediment binding was previously proposed to occur via the carboxyl group (Marengo et al., 1997) , which is essential for its antibacterial activity (Wetzstein, 2001) , complete loss of the property was expected.
Conclusions
The applied strategy for the analysis of the biodegradation of enrofloxacin in lake sediment allowed the detection and the identification of three TPs. All TPs identified were formed through modifications occurring in the essential structure of the quinolones, however, the piperazine ring remained unchanged. The antibiotic susceptibility assay showed that, after biodegradation, the products formed in the solution lost the antibiotic effects. In support, the algal growth inhibition assay suggests that the degradations products formed did not affect the growth rate of algae. It is also suggested that further investigations are needed to obtain an in-depth understanding of the effects of enrofloxacin degradation products on organisms existing in aquatic environments.
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